CD­MOs in­ves­ti­gate how to sup­port GLP-1 man­u­fac­tur­ing, phar­ma con­sid­ers sup­ply chain di­ver­si­ty: #Jef­feries23

If there were two key ideas that sprung from the CD­MO pan­el at this week’s Jef­feries Lon­don Health­care Con­fer­ence, it is that man­u­fac­tur­ers are re­view­ing how they can ex­pand in­to GLP-1s and that se­cur­ing sup­ply chains is at the back of mind for clients.

There is boom­ing de­mand for GLP-1s to the point that Sylke Has­sel, CEO of API man­u­fac­tur­er Ax­plo­ra, said that it’s akin to the surge of de­mand for Covid vac­cines dur­ing the height of the pan­dem­ic.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER